ABSTRACT
Objetivo. Determinar la bioactividad de trece plantas medicinales peruanas a través de su capacidad citotóxica. Materiales y métodos. Se elaboraron extractos acuosos, hidroalcohólicos, o zumos liofilizados de las especies vegetales seleccionadas. La citotoxicidad in vitro fue evaluada usando la prueba de letalidad de Artemia salina, con la determinación de la concentración letal media (CL50). El potencial citotóxico de las muestras de extractos evaluados, se clasificaron en: a) no tóxico: CL50 > 1000 µg/ mL; b) baja toxicidad: 500 < CL50 ≤ 1000 µg/ mL; c) toxicidad moderada: 100 < CL50 ≤ 500 µg/ mL, y d) alta toxicidad: CL50 < 100 µg/ mL. Resultados. Los diferentes extractos del rizoma de Curcuma longa mostraron una potente actividad citotóxica, con CL50 entre 20,67 ± 7,04 y 98,14± 2,64 ug/mL. Los extractos de rizoma de Zingiber officinale, del fruto de Physalis angulata y la planta entera de Physalis angulata también mostraron actividad citotóxica con CL50 de 87,15±18,17, 323,48±18,85 y 328,92±23,08 ug/mL, respectivamente. Conclusión. Se encontró actividad citotóxica en los extractos de los rizomas de Curcuma longa, Zingiber officinale, así como el fruto y planta entera de Physalis angulata. Futuros estudios podrán determinar si la flora cultivada en el Perú puede ser una fuente para el desarrollo futuro de agentes antitumorales.
Objective. To determine the bioactivity of 13 Peruvian medicinal plants through their cytotoxic capacity. Material and methods. Aqueous, hydroalcoholic extracts or lyophilized juices of the selected plant species were elaborated. In vitro cytotoxicity was evaluated using the Artemia salina lethality test, with the determination of the mean lethal concentration (LC50). The cytotoxic potential of the samples of evaluated extracts was classified into: a) non-toxic: LC50> 1000 µg / mL, b) low toxicity: 500 < LC50 ≤ 1000 µg / mL, c) moderate toxicity: 100 < LC50≤ 500 µg / mL, and d) high toxicity: LC50 <100 µg / mL. Results. The different extracts of the Curcuma longa's rhizome showed a potent cytotoxic activity, with LC50 between 20.67 ± 7.04 and 98.14 ± 2.64 µg / mL. Zingiber officinale rhizome, Physalis angulate fruit and Physalis angulata whole plant extracts, also showed cytotoxic activity with LC50 of 87.15 ± 18.17, 323.48 ± 18.85 and 328.92 ± 23.08 µg / mL, respectively. Conclusion. Cytotoxic activity was found in the extracts of Curcuma longa, Zingiber officinale rhizomes, as well as Physalis angulata fruit and whole plant extracts. Future studies will be able to determine if the flora cultivated in Peru could be a source for future development of antitumoral agents.
Subject(s)
Ginger/toxicity , Curcuma/toxicity , Physalis/toxicity , Peru , Plants, Medicinal , Artemia , In Vitro Techniques , Plant Extracts , Medicine, TraditionalABSTRACT
Physalis angulata L (Solanaceae) is a medicinal plant from North of Brazil, whose different extracts and infusions are commonly used in the popular medicine for the treatment of malaria, asthma, hepatitis, dermatitis and rheumatism. However, the genotoxic effects of P. angulata on human cells is not well known. The main purpose of the present study was to evaluate the in vitro genotoxic effects of aqueous extract of P. angulata using the comet assay and the micronucleus assay in human lymphocytes provided from 6 healthy donors. Treatments with P. angulata extracts were performed in vitro in order to access the extent of DNA damage. The comet assay has shown that treatments with P. angulata at 0.5, 1.0, 2.0, 3.0 and 6.0 microg/mL in culture medium were genotoxic. Lymphocytes treated with P. angulata at the concentrations of 3.0 and 6.0 microg/mL in culture medium showed a statistically significant increase in the frequency of micronucleus (p<0.05), however, the cytokinesis blocked proliferation index (CBPI) was not decreased after P. angulata treatment. In conclusion, the present work demonstrated the genotoxic effects of P. angulata extract on human lymphocytes in vitro.